InvestorsHub Logo
Followers 0
Posts 70
Boards Moderated 0
Alias Born 09/06/2007

Re: None

Monday, 06/23/2008 9:17:33 AM

Monday, June 23, 2008 9:17:33 AM

Post# of 580
Europe grants Orphan Drug status

"TORONTO, June 23 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" or the "Corporation"), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, today announced that its lead Clinical drug, LOR-2040, has been granted Orphan Drug status for the treatment of Acute Myeloid Leukemia (AML) by the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA)"

They are currently on PH !!, this should smooth and speed up path to approval.
Norman
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News